Sangam Health Care Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve 1. Unaudited financial ....
Awaiting price reaction for this filing.
The company has informed BSE that its Board of Directors will meet on Thursday, 13 November 2025 at the registered office. The key items on the agenda are the unaudited financial results for the quarter ended 30 September 2025 (Q2 FY26) and the limited review report by auditors for the same period. The notice also includes a standard 'any other business' clause with the Chair's permission. No actual financial numbers are shared in this filing — it is only a pre-meeting intimation as required by SEBI listing rules.
Routine regulatory disclosure with no immediate impact on shareholders or the stock. Investors should watch for the actual results announcement after the 13 November 2025 board meeting for any meaningful business or earnings signals.